Source: Health Products Regulatory Authority (IE) Revision Year: 2021 Publisher: G.L. Pharma GmbH, Schlossplatz 1, 8502 Lannach, Austria
Potassium iodide G.L. Pharma 65 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Diameter: about 8.3 mm. Thickness: 3.2-3.8 mm. White to brown-white, round, curved tablet with a pressure-sensitive cross break line on the inner side and notches on the outer side. The tablet can be divided into equal doses. |
1 tablet contains 65 mg potassium iodide, equivalent to 50 mg iodine.
Excipient with known effect: 1 tablet contains 80 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Potassium iodide |
Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities. |
| List of Excipients |
|---|
|
Maize starch |
Blister packs: PVC-PVdC/aluminium blister containing 2, 4, 6, 10, and 20 tablets
Not all pack sizes may be marketed.
G.L. Pharma GmbH, Schlossplatz 1, 8502 Lannach, Austria
PA1770/001/001
Date of first authorisation: 3rd August 2012
Date of last renewal: 5th April 2016
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
